Immunoclin Corp Deferred Revenue
Immunoclin Corp had Deferred Revenue of $745.13 thousand as of 2014-10-31, per its 10-Q filed 2014-12-22.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2014-12-22
- 2014-10-31: Deferred Revenue, Current $745.13K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2014-10-31 | $745.13K 10-Q · filed 2014-12-22 |